Literature DB >> 12244147

Differential functions of IL-4 receptor types I and II for dendritic cell maturation and IL-12 production and their dependency on GM-CSF.

Manfred B Lutz1, Markus Schnare, Mauritius Menges, Susanne Rössner, Martin Röllinghoff, Gerold Schuler, André Gessner.   

Abstract

Little is known about the distinct roles of the two types of IL-4R on DC. Here we report that IL-4 and IL-13 are able to promote DC maturation, as evaluated by up-regulation of MHC class II and costimulatory molecules, when the concentration of GM-CSF is relatively lower than the dose of IL-4 or IL-13. In addition, under these conditions both cytokines enable DC to respond to maturation stimuli such as bacterial products or proinflammatory cytokines. Both IL-4 and IL-13 act synergistically with weak maturation stimuli such as TNF-alpha or CD40. The IL-4R signaling for DC maturation requires the IL-4R alpha-chain and STAT6, but not Janus kinase 3, indicating that IL-4R type II signaling is preferentially responsible for these effects. In contrast, the production of IL-12 p70, but not IL-10 and TNF, induced by microbial products was enhanced only by IL-4, not by IL-13 or Y119D, a selective type II IL-4R agonist, in vitro and in vivo. This enhancement was dependent on the presence of Janus kinase 3, indicating that this function is exclusively mediated by the type I IL-4R. In short, we discerned the individual roles of the two IL-4R types on DC function, showing that IL-4R type I promotes IL-12 secretion independently of GM-CSF concentration, while IL-4R type II promotes the up-regulation of MHC class II and costimulatory surface markers in a GM-CSF concentration-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12244147     DOI: 10.4049/jimmunol.169.7.3574

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  Alternatively activated dendritic cells regulate CD4+ T-cell polarization in vitro and in vivo.

Authors:  Peter C Cook; Lucy H Jones; Stephen J Jenkins; Thomas A Wynn; Judith E Allen; Andrew S MacDonald
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-01       Impact factor: 11.205

2.  Inhibiting STAT5 by the BET bromodomain inhibitor JQ1 disrupts human dendritic cell maturation.

Authors:  Patricia A Toniolo; Suhu Liu; Jennifer E Yeh; Pedro M Moraes-Vieira; Sarah R Walker; Vida Vafaizadeh; José Alexandre M Barbuto; David A Frank
Journal:  J Immunol       Date:  2015-02-27       Impact factor: 5.422

3.  Early exposure of interferon-γ inhibits signal transducer and activator of transcription-6 signalling and nuclear factor κB activation in a short-term monocyte-derived dendritic cell culture promoting 'FAST' regulatory dendritic cells.

Authors:  D Rojas-Canales; R Krishnan; C F Jessup; P T Coates
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

4.  Characterisation of a dendritic cell subset in synovial tissue which strongly expresses Jak/STAT transcription factors from patients with rheumatoid arthritis.

Authors:  J G Walker; M J Ahern; M Coleman; H Weedon; V Papangelis; D Beroukas; P J Roberts-Thomson; M D Smith
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

5.  Generation of bone marrow derived murine dendritic cells for use in 2-photon imaging.

Authors:  Melanie P Matheu; Debasish Sen; Michael D Cahalan; Ian Parker
Journal:  J Vis Exp       Date:  2008-07-09       Impact factor: 1.355

6.  Resident renal mononuclear phagocytes comprise five discrete populations with distinct phenotypes and functions.

Authors:  Takahisa Kawakami; Julia Lichtnekert; Lucas J Thompson; Prasanthi Karna; Hicham Bouabe; Tobias M Hohl; Jay W Heinecke; Steven F Ziegler; Peter J Nelson; Jeremy S Duffield
Journal:  J Immunol       Date:  2013-08-16       Impact factor: 5.422

Review 7.  The potential for genetically altered microglia to influence glioma treatment.

Authors:  W Li; R M D Holsinger; C A Kruse; A Flügel; M B Graeber
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-09       Impact factor: 4.388

Review 8.  Janus kinases in immune cell signaling.

Authors:  Kamran Ghoreschi; Arian Laurence; John J O'Shea
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

9.  Targeting IL-4/IL-13 signaling to alleviate oral allergen-induced diarrhea.

Authors:  Eric B Brandt; Ariel Munitz; Tatyana Orekov; Melissa K Mingler; Melissa McBride; Fred D Finkelman; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2008-11-08       Impact factor: 10.793

10.  A new mechanism for inhalational priming: IL-4 bypasses innate immune signals.

Authors:  Anna M Dittrich; Hui-Chen Chen; Lan Xu; Patricia Ranney; Sean Connolly; Timur O Yarovinsky; H Kim Bottomly
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.